Financials

News Discussions Technicals Seasonals

2105 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Laekna, Inc. engages in the provision of clinical stage research and development of biopharmaceutical products. It primarily focuses on cancer and liver fibrosis. The company was founded by Xiang Yang Lu on July 29, 2016 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

2105 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company